Project Will Develop and Evaluate a New Program to Reduce Crime, Recidivism and Illegal Substance Use in Seven Middle Tennessee Counties
Bloomington, Ind. and Nashville, Tenn.—The Centerstone Research Institute (CRI), a company of Centerstone, the nation’s largest provider of community-based behavioral healthcare, today announced that it has secured a three-year, $1.2 million grant from the Substance Abuse and Mental Health Services Administration (SAMHSA). The grant will fund the creation and evaluation of a new Tennessee program serving adults with substance abuse or co-occurring substance abuse and mental health disorders who are involved in community criminal justice systems. The program will target the following counties: Bedford, Coffee, Franklin, Grundy, Lincoln, Moore and Warren.
“There is a significant gap in the continuum of care for adult public offenders who have substance abuse issues or co-occurring mental health disorders,” said Dennis Morrison, Ph.D., CEO of CRI. “Persons living in the community who are involved with the criminal justice system and have substance abuse and/or co-occurring issues face special risk for relapse. Providing offenders with the therapeutic tools to help them get and stay clean has great potential for reducing crime and keeping our communities safer.”
Of the 15,000 offenses reported in Bedford, Coffee, Franklin, Grundy, Lincoln, Moore and Warren counties in 2006, 32 percent of local arrestees were charged with substance-related offenses, and it is estimated that more than 64 percent of arrests involved substances. However, within this seven-county area, there are no local substance abuse programs that specialize in addressing the unique treatment needs of community residents who are involved with the criminal justice system.
As a part of the new grant secured by CRI, Centerstone will receive funds to create an evidence-based substance abuse treatment program for up to 220 offenders in Bedford, Coffee, Franklin, Grundy, Lincoln, Moore and Warren. To evaluate the program, CRI will examine the mental, emotional and physical well-being of program participants at admission, discharge and six months following discharge to evaluate linkages between the program’s efficacy and outcomes.
The study conducted by CRI will use federally mandated Government Performance and Results Act (GRPA) data analysis tools, as well as the Outcome Questionnaire-45 (OQ45) and the 12-Item Short-Form Health Survey (SF-12) to assess participants’ mental health and symptomatology and physical health, respectively.
The new program created by Centerstone will aim to reduce substance use, costs related to substance use and substance abuse-related incarceration by 70 percent through treatment and therapeutic support. Services offered by Centerstone will include subject screening and assessment, outpatient and intensive outpatient treatment, case management, substance abuse education for individuals and families, relapse prevention, drug testing and monitoring, and other recovery support services. In addition, Centerstone’s program will engage in community education with the goal of reaching 3,500 individuals.
About The Centerstone Research Institute
The Centerstone Research Institute (CRI), a company of Centerstone, is linking science to clinical service through diverse privately and publicly funded research studies and community based projects. The company works both independently and in collaboration with major academic institutions. Since 2001, CRI has conducted more than 100 service and clinical studies ranging from medication management for mental illness to suicide prevention in older adults. CRI maintains an Institutional Review Board and manages the Knowledge Network, a technology-based, partner-driven alliance to facilitate the translation of research to practice. The company also offers Behavioral Pathway Systems, a best practices benchmarking service.